One-year impact on HPV vaccination coverage of a school- and primary care-based intervention: the PrevHPV cluster randomised trial (opens in new tab)

Human papillomavirus (HPV) vaccine coverage (VC) remains suboptimal in many countries. The PrevHPV national research programme aimed to codevelop and evaluate a three-component intervention including: ‘education and motivation’ of adolescents, ‘at-school vaccination’, ‘general practitioners (GPs)’ training’. We assessed its impact on VC at one year through a cluster randomized trial (July 2021–April 2022) conducted in French municipalities (clusters) receiving 0, 1, 2, or 3 components. The ou...